Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
8.66
+0.35 (4.21%)
Apr 24, 2025, 4:00 PM EDT - Market closed

Avadel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
8371,013----
Upgrade
Enterprise Value
796985----
Upgrade
Last Close Price
8.6010.51----
Upgrade
Forward PE
64.35200.19----
Upgrade
PS Ratio
4.845.99----
Upgrade
PB Ratio
11.2413.71----
Upgrade
P/TBV Ratio
14.5817.76----
Upgrade
EV/Sales Ratio
4.715.83----
Upgrade
Debt / Equity Ratio
0.530.530.41-6.201.850.80
Upgrade
Asset Turnover
1.031.030.19--0.10
Upgrade
Inventory Turnover
1.001.00----
Upgrade
Quick Ratio
2.212.213.181.778.9917.30
Upgrade
Current Ratio
2.752.753.641.819.1717.44
Upgrade
Return on Equity (ROE)
-60.44%-60.44%-481.35%-481.49%-64.30%10.56%
Upgrade
Return on Assets (ROA)
-16.11%-16.11%-57.92%-31.32%-19.14%-9.90%
Upgrade
Return on Capital (ROIC)
-22.41%-22.41%-73.72%-35.73%-20.73%-11.64%
Upgrade
Earnings Yield
-5.88%-4.82%----
Upgrade
FCF Yield
-5.64%-4.63%----
Upgrade
Buyback Yield / Dilution
-18.67%-18.67%-33.41%-2.66%-6.54%-46.89%
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q